Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-24 @ 11:53 PM
NCT ID:
NCT00405951
Eligibility Criteria:
Inclusion Criteria:
* Pathological confirmation of Non-Small Cell Lung Cancer (NSCLC)
* Must have been previously treated with a single platinum-based chemotherapy regimen and shown evidence of disease progression; no further limitations
* Must have normal organ function
* Must be willing to submit to blood sampling for planned PK and PD analysis
* Must have the ability to understand and willingness to sign a written informed consent form
Exclusion Criteria:
* No other agents or therapies administered with the intent to treat malignancy
* Patients with prior exposure to obatoclax or docetaxel
* Uncontrolled, intercurrent illness
* Pregnant women and women who are breast feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00405951
Study Brief:
Protocol Section:
NCT00405951